Privia Health Group (NASDAQ:PRVA) Price Target Raised to $33.00

by · The Cerbat Gem

Privia Health Group (NASDAQ:PRVA – Get Free Report) had its target price raised by equities research analysts at JPMorgan Chase & Co. from $32.00 to $33.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.73% from the company’s previous close.

Other equities analysts also recently issued reports about the stock. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. JMP Securities upped their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, August 29th. BMO Capital Markets began coverage on Privia Health Group in a research report on Thursday. They issued an “outperform” rating and a $30.00 price objective on the stock. Canaccord Genuity Group raised their price target on Privia Health Group from $32.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Citizens Jmp boosted their price objective on shares of Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research report on Friday, November 7th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Privia Health Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $30.00.

Check Out Our Latest Stock Analysis on Privia Health Group

Privia Health Group Trading Down 1.8%

Shares of PRVA traded down $0.43 during midday trading on Thursday, reaching $23.79. The stock had a trading volume of 272,642 shares, compared to its average volume of 847,420. The company’s 50-day moving average is $24.20 and its 200 day moving average is $22.78. The company has a market capitalization of $2.93 billion, a price-to-earnings ratio of 182.88, a price-to-earnings-growth ratio of 3.45 and a beta of 0.83. Privia Health Group has a 12-month low of $18.77 and a 12-month high of $26.51.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last issued its earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The company had revenue of $213.61 million for the quarter. Research analysts forecast that Privia Health Group will post 0.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Franklin Resources Inc. lifted its stake in shares of Privia Health Group by 19.1% in the 3rd quarter. Franklin Resources Inc. now owns 1,596,634 shares of the company’s stock worth $39,756,000 after purchasing an additional 256,236 shares during the period. Legal & General Group Plc grew its position in shares of Privia Health Group by 3.4% during the 3rd quarter. Legal & General Group Plc now owns 292,901 shares of the company’s stock valued at $7,293,000 after acquiring an additional 9,693 shares during the period. Vestcor Inc increased its stake in shares of Privia Health Group by 109.5% in the 3rd quarter. Vestcor Inc now owns 19,638 shares of the company’s stock worth $489,000 after purchasing an additional 10,265 shares in the last quarter. Swiss National Bank raised its holdings in Privia Health Group by 1.7% in the 3rd quarter. Swiss National Bank now owns 189,100 shares of the company’s stock worth $4,709,000 after purchasing an additional 3,200 shares during the period. Finally, Russell Investments Group Ltd. lifted its position in Privia Health Group by 33,783.6% during the third quarter. Russell Investments Group Ltd. now owns 20,669 shares of the company’s stock valued at $515,000 after purchasing an additional 20,608 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Recommended Stories